Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 401-404 of 404 for multiple

Edit search filters
  1. A Study to Analyse the Genetic Makeup of Those with Opioid and Substance Use Disorders

    Albert Lea, MN, Rochester, MN

  2. Advanced Registry Technology for MS and Neuroimmunological Disorders

    La Crosse, WI

  3. A Study About Comparing a New Test of Blood Clotting with Standard Tests of Blood Clotting in Patients Who are Undergoing Heart Surgery

    Rochester, MN

  4. Randomized Controlled Trial to Compare the Operative Outcomes and Complications of Mini-Percutaneous Nephrolithotomy (mini-PCNL) Versus Standard PCNL

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer